I am academic turned founder & CEO of Matriks Biotechnology, established in 2002, Ankara, Turkey. Over the last 34 years, my career has covered 23 years of research and teaching at Medical School in Ankara University and the 22 years of research & development and business at Matriks Biotechnology. My research interests are; Medical Biotechnology, Biotherapy Drug Monitoring (PK/immunogenicity), Inflammation, Metabolic Disorders, Fungal (yeast) Infections (diagnosis and treatment) and post covid research regarding to inflammation and autoimmunity. Matriks Biotek® is globally the first and leading company to introduce commercial ELISA kits for biotherapy monitoring and creating the worldwide market.Products are in the market for 16 years. Present in over 40 countries and 30 pharmaceutical companies used our products with confidence.For my personal publications please refer to:https://www.researchgate.net/profile/Haluk_Ataoglu/publications/For publications done by using Matriks Biotek® SHIKARI® ELISA kits (over 170 publications) please refer to:http://www.matriksbiotek.com/publications.html
Listed skills include Biotechnology, Microbiology, Lifesciences, Molecular Biology, and 32 others.